We value your privacy
We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies.
We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.
The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ...
Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.
No cookies to display.
Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.
No cookies to display.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.
No cookies to display.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
No cookies to display.
Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.
No cookies to display.
$99.00
$49 Member pricing! Login to see membership pricing or become a member today!
We will discuss the two most common COVID tests available: rapid antigen tests and PCR tests.
We will discuss the two most common COVID tests available: rapid antigen tests and PCR tests. We will review how they work and their efficacy. We will then dive into the NIH guidelines for outpatient treatment of COVID including Paxlovid, Sotrovimab, Remdesivir and Molnupiravir by examining the clinical trials and clinical use of these treatments. We will wrap up with an overview of other on-the-horizon treatments including bebtelovimab and fluvoxamine.
Format | Video |
---|---|
Contributor | Lindsey Fish |
Source | Urgent Care Association |
Length | 20 minutes 18 seconds |
Publication Date | 09/22/2022 |
Notifications